Page last updated: 2024-08-24

glucose, (beta-d)-isomer and phentermine

glucose, (beta-d)-isomer has been researched along with phentermine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
le Roux, CW; Miras, AD1
Aronne, LJ; Mauer, EA; Rathi, S; Shukla, AP; Thomas, CE1
Bellanger, D; Chappell, N; Elkind-Hirsch, KE; Seidemann, E; Storment, J1

Reviews

1 review(s) available for glucose, (beta-d)-isomer and phentermine

ArticleYear
Can medical therapy mimic the clinical efficacy or physiological effects of bariatric surgery?
    International journal of obesity (2005), 2014, Volume: 38, Issue:3

    Topics: Anti-Obesity Agents; Bariatric Surgery; Benzazepines; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Exercise; Feeding Behavior; Female; Fructose; Glucagon-Like Peptide-1 Receptor; Glucosides; Glycated Hemoglobin; Homeostasis; Humans; Islet Amyloid Polypeptide; Lactones; Male; Minimally Invasive Surgical Procedures; Obesity, Morbid; Orlistat; Phentermine; Receptors, Glucagon; Topiramate; Treatment Outcome; Weight Loss

2014

Trials

1 trial(s) available for glucose, (beta-d)-isomer and phentermine

ArticleYear
Exenatide, Dapagliflozin, or Phentermine/Topiramate Differentially Affect Metabolic Profiles in Polycystic Ovary Syndrome.
    The Journal of clinical endocrinology and metabolism, 2021, 09-27, Volume: 106, Issue:10

    Topics: Adolescent; Adult; Benzhydryl Compounds; Blood Glucose; Drug Therapy, Combination; Exenatide; Female; Glucose Tolerance Test; Glucosides; Humans; Hypoglycemic Agents; Metformin; Middle Aged; Obesity; Phentermine; Polycystic Ovary Syndrome; Prospective Studies; Single-Blind Method; Topiramate; Treatment Outcome; Weight Loss; Young Adult

2021

Other Studies

1 other study(ies) available for glucose, (beta-d)-isomer and phentermine

ArticleYear
Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s.
    Obesity (Silver Spring, Md.), 2016, Volume: 24, Issue:9

    Topics: Anti-Obesity Agents; Benzhydryl Compounds; Databases, Factual; Drug Prescriptions; Glucosides; Humans; Hypoglycemic Agents; Obesity; Phentermine; Practice Patterns, Physicians'; Retrospective Studies; United States; Weight Loss

2016